Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Public ClinicalTrials.gov record NCT02140255. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study
Study identification
- NCT ID
- NCT02140255
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Enrollment
- 1,120 participants
Conditions and interventions
Conditions
Interventions
- Dolutegravir (DTG) Drug
- Lopinavir/Ritonavir (LPV/r) Drug
- Nevirapine (NVP) Drug
- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Drug
- Raltegravir (RAL) Drug
- VRC01 Drug
- VRC07-523LS Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 48 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 22, 2015
- Primary completion
- Jan 30, 2028
- Completion
- Dec 30, 2031
- Last update posted
- Apr 27, 2026
2015 – 2031
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 4601, University of California, San Diego Clinical Research Site | La Jolla | California | 92093-0672 | Completed |
| 5048, University of Southern California Clinical Research Site | Los Angeles | California | 90089 | Recruiting |
| 5112, David Geffen School of Medicine at UCLA Clinical Research Site | Los Angeles | California | 90095-1752 | Recruiting |
| 5052, University of Colorado, Denver Clinical Research Site | Aurora | Colorado | 80045 | Recruiting |
| 5055, South Florida CDTC Fort Lauderdale Clinical Research Site | Fort Lauderdale | Florida | 33316 | Completed |
| 5051, University of Florida Center for HIV/AIDS Research, Education and Service (UF CARES) Clinical Research Site | Jacksonville | Florida | 32209 | Recruiting |
| 5127, Pediatric Perinatal HIV Clinical Research Site | Miami | Florida | 33136 | Recruiting |
| Emory University School of Medicine NICHD CRS | Atlanta | Georgia | 30322 | Withdrawn |
| 5083, Rush University Cook County Hospital Clinical Research Site | Chicago | Illinois | 60612 | Recruiting |
| 4001, Lurie Children's Hospital of Chicago Clinical Research Site | Chicago | Illinois | 60614-3393 | Recruiting |
| 5092, Johns Hopkins Clinical Research Site | Baltimore | Maryland | 21287 | Recruiting |
| Boston Medical Center Ped. HIV Program NICHD CRS | Boston | Massachusetts | 02118 | Withdrawn |
| 5040, SUNY Stony Brook Clinical Research Site | Stony Brook | New York | 11794 | Withdrawn |
| 5114, Bronx Lebanon Hospital Center Clinical Research Site | The Bronx | New York | 10457 | Recruiting |
| 5013, Jacobi Medical Center Clinical Research Site | The Bronx | New York | 10461 | Recruiting |
| Philadelphia IMPAACT Unit CRS | Philadelphia | Pennsylvania | 9104 | Withdrawn |
| 6501, St Jude Children's Research Hospital Clinical Research Site | Memphis | Tennessee | 38105-3678 | Recruiting |
| 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site | Houston | Texas | 77030 | Recruiting |
| Seattle Children's Research Institute CRS | Seattle | Washington | 98101 | Withdrawn |
| Univ. of Washington NICHD CRS | Seattle | Washington | 98195 | Withdrawn |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02140255, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02140255 live on ClinicalTrials.gov.